<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> is a potent <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and free radical scavenger </plain></SENT>
<SENT sid="1" pm="."><plain>Previously, we showed that a single injection of <z:chebi fb="9" ids="16796">melatonin</z:chebi> before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> significantly reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in both permanent and 3-hr middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) rat <z:hpo ids='HP_0001297'>stroke</z:hpo> models </plain></SENT>
<SENT sid="2" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) and other free radicals play an important role in the pathogenesis of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, and they have been postulated to mediate the breakdown of the blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we evaluated the influence of <z:chebi fb="9" ids="16796">melatonin</z:chebi>, given at 30 min before MCAO, on brain NO concentration and <z:chebi fb="2" ids="33602">BBB</z:chebi> breakdown </plain></SENT>
<SENT sid="4" pm="."><plain>Brain NO concentration was measured at 15 min of MCAO using electron paramagnetic resonance spectroscopy </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="2" ids="33602">BBB</z:chebi> breakdown at 3 hr of reperfusion following 3 hr of MCAO was assessed using Evans blue extravasation </plain></SENT>
<SENT sid="6" pm="."><plain>The relative brain NO concentration was increased to 141.69 +/- 9.71% (mean +/- S.E.M.; n = 9) at 15 min of MCAO </plain></SENT>
<SENT sid="7" pm="."><plain>Treatment with <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 1.5, 5, or 50 mg/kg significantly reduced the brain NO concentration to 104.20 +/- 11.20% (n = 8), 55.67 +/- 5.58% (n = 11), and 104.86 +/- 12.56% (n = 9), respectively </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> at 5 mg/kg did not affect Evans blue extravasation </plain></SENT>
<SENT sid="9" pm="."><plain>Our results suggest that a single injection of <z:chebi fb="9" ids="16796">melatonin</z:chebi> protects against focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> partly via inhibition of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced NO production and that this regimen does not prevent <z:chebi fb="2" ids="33602">BBB</z:chebi> breakdown following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
</text></document>